journal article·2018-03

A novel expandable porous composite based on acetalized polyvinyl alcohol and calcium sulfate used for injectable bone repair materials

Hongyu Du, Yudong Zheng, Wei He, Yi Sun, Yansen Wang

Publisher page

Abstract

Abstract Calcium sulfate hemihydrate (CaSO4·1/2H2O; CSH) has been used for filling bone defects because of its excellent biocompatibility and injectability. Researchers have devoted in improving its performance to adapt to various demands. However, up to now, no studies have reported bone cement with expandable ability. In this study, a novel expandable bone cement was prepared with acetalized polyvinyl alchol porous material (APVA-PM) and CSH. By controlling the content of APAV-PM, composite cements with different structures and morphology were obtained and investigated by using SEM, FT-IR, XRD. The physical properties including setting time, porosity and expansion ratio were studied. CSH/APVA-PM bone cement could produce volume expansion in the setting process and form a porous structure after curing. The setting time decreased with the increase of the volume fraction of APVA-PM. APVA-PM improved the toughness of calcium sulfate cement, thus overcoming the present mechanical limitations. In vitro experiments demonstrated the CSH/APVA-PM bone cement did not show cytotoxicity and the porous structure allowed the rat bone marrow stem cells (BMSCs) to grow into the pores. Therefore, CSH/APVA-PM bone cement appeared to be useful for bone tissue engineering and can potentially serve as a new filling material.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Evaluation and management of vertebral compression fractures10.7812/TPP/12-037 ↗
2. Vertebral fractures10.1056/NEJMcp1009697 ↗
3. Catastrophic intramedullary hematoma following Kümmell's disease with large intravertebral cleft10.1016/j.spinee.2007.07.397 ↗
4. Efficacy of percutaneous vertebroplasty in the treatment of intravertebral pseudarthrosis associated with noninfected avascular necrosis of the vertebral body10.1097/01.BRS.0000076824.61074.06 ↗
5. Delayed vertebral collapse with neurological deficits secondary to osteoporosis10.1007/s00264-002-0418-5 ↗
6. New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures10.1097/00007632-200107150-00002 ↗
7. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients10.3171/spi.2003.98.1.0021 ↗
8. The role of polymethylmethacrylate bone cement in modern orthopaedic surgery
9. A comparison of the shrinkage of commercial bone cements when mixed under vacuum
10. Effect of gypsum on proliferation and differentiation of MC3T3-E1 mouse osteoblastic cells10.1016/j.biomaterials.2006.09.002 ↗
11. Regeneration of bone in the presence of calcium sulfate10.1001/archotol.1980.00790310029007 ↗
12. Improved workability of injectable calcium sulfate bone cement by regulation of self-setting properties10.1016/j.msec.2012.11.019 ↗
13. Biocompatibility of artificial bone based on vancomycin loaded mesoporous silica nanoparticles and calcium sulfate composites10.1007/s10856-016-5671-z ↗
14. Biocompatibility of calcium phosphate bone cement with optimized mechanical properties10.1002/jbm.b.33370 ↗
15. Preparation and characterization of a silk fibroin/calcium sulfate bone cement10.1002/jbm.b.33855 ↗
16. Preparation and physical characterization of calcium sulfate cement/silica-based mesoporous material composites for controlled release of BMP-2
17. Effects of water-holding capability of the PVF sponge on the adhesion and differentiation of rat bone marrow stem cell culture10.1002/jbm.a.34695 ↗
18. Effects of the water-holding capability of polyvinyl formal sponges on osteogenic ability in in vivo experiments10.1002/jbm.b.33200 ↗
19. Lactose biosensor based on lactase and galactose oxidase immobilized in polyvinyl formal10.1080/10731190701460309 ↗
20. Synthesis of polyvinyl formal sponge for wound care dressing application
21. Effects of degree of acetalization and pore structure on water absorbency and mechanical properties of polyvinyl formal (PVF) porous material
22. Some factors controlling the injectability of calcium phosphate bone cements10.1023/A:1008811215655 ↗
23. The effect of plaster (CaSO4· 1/2H2O) on the compressive strength, self-setting property, and in vitro bioactivity of silicate-based bone cement10.1002/jbm.b.32837 ↗
24. Improvement on the performance of bone regeneration of calcium sulfate hemihydrate by adding mineralized collagen10.1089/ten.tea.2009.0669 ↗
25. Mechanical properties and in vitro bioactivity of injectable and self-setting calcium sulfate/nano-HA/collagen bone graft substitute10.1016/j.jmbbm.2011.12.007 ↗
26. Current progress in bioactive ceramic scaffolds for bone repair and regeneration10.3390/ijms15034714 ↗
27. Combined effect of a microporous layer and type I collagen coating on a biphasic calcium phosphate scaffold for bone tissue engineering10.3390/ma8031150 ↗
28. Preparation and characterisation of an innovative injectable calcium sulphate based bone cement for vertebroplasty application10.1039/C6TB02139E ↗
29. Osteotransductive bone cements10.1243/0954411981534196 ↗
30. The effects of temperature on the behaviour of an apatitic calcium phosphate cement10.1007/BF00134332 ↗
31. Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects10.1016/j.biomaterials.2013.09.002 ↗
32. RhBMP-2 loaded 3D-printed mesoporous silica/calcium phosphate cement porous scaffolds with enhanced vascularization and osteogenesis properties10.1038/srep41331 ↗
33. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
34. Novel approach to fabricate porous sponges of poly (D, L-lactic-co-glycolic acid) without the use of organic solvents10.1016/0142-9612(96)87284-X ↗
35. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K ↗
36. The composite of hydroxyapatite and calcium sulphate: a review of preclinical evaluation and clinical applications10.1586/17434440.2013.827529 ↗
37. Fabrication of injectable and expandable PMMA/PAAS f bone cements10.1016/j.compscitech.2017.04.032 ↗
38. Simultaneous reinforcement and toughening of polymer/hydroxyapatite composites by constructing bone-like structure10.1016/j.compscitech.2017.08.026 ↗
39. Bone volume fraction explains the variation in strength and stiffness of cancellous bone affected by metastatic cancer and osteoporosis10.1007/s00223-008-9174-x ↗
40. A new method to produce macroporous Mg-phosphate bone growth substitutes10.1016/j.msec.2017.02.111 ↗
41. Bone morphogenetic protein-2 immobilization on porous PCL-BCP-Col composite scaffolds for bone tissue engineering10.1002/app.45186 ↗
42. Angiogenin-loaded fibrin/bone powder composite scaffold for vascularized bone regeneration10.1186/s40824-015-0040-4 ↗
43. Influences of mesoporous magnesium silicate on the hydrophilicity, degradability, mineralization and primary cell response to a wheat protein based biocomposite10.1039/C6TB01449F ↗
44. Fiber reinforced calcium phosphate cements–On the way to degradable load bearing bone substitutes?10.1016/j.biomaterials.2012.04.053 ↗
45. An in situ synthesis of mesoporous SBA-16/hydroxyapatite for ciprofloxacin release: in vitro stability and cytocompatibility studies10.1007/s10856-014-5273-6 ↗